#NAD is all the rage in the healthy aging space.
But a @UDelaware clinical trial is casting doubt that nicotinamide riboside (NR), a widely marketed NAD+ precursor supplement, delivers many of the benefits touted online.
Read more in UDaily ⬇️
🔗 brnw.ch/21x4joB

